• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏淤血和肠道微环境在心力衰竭进展中的作用。

The role of splanchnic congestion and the intestinal microenvironment in the pathogenesis of advanced heart failure.

机构信息

Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

出版信息

Curr Opin Support Palliat Care. 2019 Mar;13(1):24-30. doi: 10.1097/SPC.0000000000000414.

DOI:10.1097/SPC.0000000000000414
PMID:30640740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6366455/
Abstract

PURPOSE OF REVIEW

Right-sided heart failure, which is often present in the setting of advanced heart failure, is associated with cardiac cachexia, the cardiorenal syndrome, and adverse outcomes. Improved understanding of venous congestion of the splanchnic circulation, which may play a key role in the pathogenesis of right-sided heart failure, could lead to novel therapeutics to ameliorate heart failure. Here we provide an overview of right-sided heart failure, splanchnic hemodynamics, fluid homeostasis, and the intestinal microenvironment. We review recent literature to describe pathophysiologic mechanisms and possible therapeutics.

RECENT FINDINGS

Several possible mechanisms centered around upregulation of sodium-hydrogen exchanger-3 (NHE3) may form a causal link between right ventricular dysfunction, splanchnic congestion, and worsening heart failure. These include an anaerobic environment in enterocytes, resulting in reduced intracellular pH; increased sodium absorption by the gut via NHE3; decreased pH at the intestinal brush border thus altering the gut microbiome profile; increased bacterial synthesis of trimethylamine N-oxide; and decreased bacterial synthesis of short-chain fatty acids causing abnormal intestinal barrier function.

SUMMARY

Splanchnic congestion in the setting of right-sided heart failure may serve an important role in the pathogenesis of advanced heart failure, and further exploration of these mechanisms may lead to new therapeutic advances.

摘要

目的综述

右心衰竭常发生于晚期心力衰竭患者,与心脏恶病质、心肾综合征和不良预后相关。对内脏循环静脉淤血(可能在右心衰竭发病机制中起关键作用)的理解的提高,可能会带来改善心力衰竭的新疗法。本文概述了右心衰竭、内脏血流动力学、液体平衡和肠道微环境,并复习了相关文献,以描述病理生理机制和可能的治疗方法。

最近的发现

几种可能的机制集中在钠氢交换体 3(NHE3)的上调上,可能在右心室功能障碍、内脏淤血和心力衰竭恶化之间形成因果关系。这些机制包括肠细胞中的厌氧环境导致细胞内 pH 值降低;肠道通过 NHE3 吸收更多的钠;肠道刷状缘的 pH 值降低,从而改变肠道微生物组谱;细菌合成三甲胺 N-氧化物增加;以及短链脂肪酸合成减少导致肠道屏障功能异常。

总结

右心衰竭时的内脏淤血可能在晚期心力衰竭的发病机制中起重要作用,对这些机制的进一步探索可能会带来新的治疗进展。

相似文献

1
The role of splanchnic congestion and the intestinal microenvironment in the pathogenesis of advanced heart failure.内脏淤血和肠道微环境在心力衰竭进展中的作用。
Curr Opin Support Palliat Care. 2019 Mar;13(1):24-30. doi: 10.1097/SPC.0000000000000414.
2
Visceral Congestion in Heart Failure: Right Ventricular Dysfunction, Splanchnic Hemodynamics, and the Intestinal Microenvironment.心力衰竭中的内脏充血:右心室功能障碍、内脏血流动力学和肠道微环境
Curr Heart Fail Rep. 2017 Dec;14(6):519-528. doi: 10.1007/s11897-017-0370-8.
3
Abdominal contributions to cardiorenal dysfunction in congestive heart failure.充血性心力衰竭中心肾功能障碍的腹部贡献。
J Am Coll Cardiol. 2013 Aug 6;62(6):485-95. doi: 10.1016/j.jacc.2013.04.070. Epub 2013 Jun 7.
4
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.微生物群与心力衰竭的交叉点:重新审视肠道假说。
J Card Fail. 2015 Dec;21(12):973-80. doi: 10.1016/j.cardfail.2015.09.017. Epub 2015 Oct 3.
5
Right Heart Failure and Cardiorenal Syndrome.右心衰竭与心肾综合征。
Cardiol Clin. 2020 May;38(2):185-202. doi: 10.1016/j.ccl.2020.01.004. Epub 2020 Mar 2.
6
Dietary metabolism, the gut microbiome, and heart failure.饮食代谢、肠道微生物群与心力衰竭。
Nat Rev Cardiol. 2019 Mar;16(3):137-154. doi: 10.1038/s41569-018-0108-7.
7
Exploring the Microbiome in Heart Failure.探索心力衰竭中的微生物群。
Curr Heart Fail Rep. 2016 Apr;13(2):103-9. doi: 10.1007/s11897-016-0285-9.
8
Impact of intestinal microbiota in patients with heart failure: A systematic review.心力衰竭患者肠道微生物群的影响:系统评价。
Med Clin (Barc). 2019 Nov 29;153(10):402-409. doi: 10.1016/j.medcli.2019.06.006. Epub 2019 Aug 12.
9
Heart Failure: a Punch from the Gut.心力衰竭:来自腹部的打击。
Curr Heart Fail Rep. 2024 Apr;21(2):73-80. doi: 10.1007/s11897-024-00648-y. Epub 2024 Feb 1.
10
Splanchnic circulation and metabolism in patients with acute liver failure.急性肝衰竭患者的内脏循环与代谢
Dan Med Bull. 2002 Aug;49(3):177-93.

引用本文的文献

1
Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases.运动预防心血管疾病的机制:从心血管疾病病理状态下的肠道微生物群特征中获得的见解
Rev Endocr Metab Disord. 2025 Jun 9. doi: 10.1007/s11154-025-09971-8.
2
Measurement and interpretation of central venous pressure: a narrative review.中心静脉压的测量与解读:一篇叙述性综述
Anaesthesia. 2025 Sep;80(9):1093-1102. doi: 10.1111/anae.16633. Epub 2025 Jun 3.
3
Iron Deficiency Treatment in Heart Failure-Challenges and Therapeutic Solutions.

本文引用的文献

1
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial.靶向肠道菌群治疗心力衰竭的 GutHeart 设计:一项 II 期、随机临床试验。
ESC Heart Fail. 2018 Oct;5(5):977-984. doi: 10.1002/ehf2.12332. Epub 2018 Aug 7.
2
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
3
Gut Microbe-Generated Trimethylamine -Oxide From Dietary Choline Is Prothrombotic in Subjects.
心力衰竭中铁缺乏的治疗——挑战与治疗方案
J Clin Med. 2025 Apr 24;14(9):2934. doi: 10.3390/jcm14092934.
4
Role of Gut Microbial Metabolites in Ischemic and Non-Ischemic Heart Failure.肠道微生物代谢产物在缺血性和非缺血性心力衰竭中的作用
Int J Mol Sci. 2025 Mar 2;26(5):2242. doi: 10.3390/ijms26052242.
5
Evaluation value of ultrasound on gastrointestinal function in patients with acute heart failure.超声对急性心力衰竭患者胃肠功能的评估价值
Front Cardiovasc Med. 2024 Nov 25;11:1475920. doi: 10.3389/fcvm.2024.1475920. eCollection 2024.
6
Role of Gut Microbial Metabolites in Cardiovascular Diseases-Current Insights and the Road Ahead.肠道微生物代谢物在心血管疾病中的作用:当前的认识和未来的方向。
Int J Mol Sci. 2024 Sep 23;25(18):10208. doi: 10.3390/ijms251810208.
7
Thrombosis and Thrombotic Risk in Athletes.运动员的血栓形成与血栓形成风险
J Clin Med. 2024 Aug 19;13(16):4881. doi: 10.3390/jcm13164881.
8
Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation.通过调节肠道微生物群推进心血管疾病的终身精准医学。
Gut Microbes. 2024 Jan-Dec;16(1):2323237. doi: 10.1080/19490976.2024.2323237. Epub 2024 Feb 27.
9
Tricuspid regurgitation, right ventricular function, and renal congestion: a cardiorenal triangle.三尖瓣反流、右心室功能与肾淤血:一个心肾三角区
Front Cardiovasc Med. 2023 Oct 4;10:1255503. doi: 10.3389/fcvm.2023.1255503. eCollection 2023.
10
Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?肠道微生物组成与心血管疾病:一个潜在的新治疗靶点?
Int J Mol Sci. 2023 Jul 26;24(15):11971. doi: 10.3390/ijms241511971.
肠道微生物从膳食胆碱生成的氧化三甲胺在受试者中具有促血栓形成作用。
Circulation. 2017 Apr 25;135(17):1671-1673. doi: 10.1161/CIRCULATIONAHA.116.025338.
4
Microbial Short-Chain Fatty Acids and Blood Pressure Regulation.微生物短链脂肪酸与血压调节
Curr Hypertens Rep. 2017 Apr;19(4):25. doi: 10.1007/s11906-017-0722-5.
5
High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice.高纤维饮食和乙酸盐补充改变肠道微生物群,预防高血压小鼠高血压和心力衰竭的发生。
Circulation. 2017 Mar 7;135(10):964-977. doi: 10.1161/CIRCULATIONAHA.116.024545. Epub 2016 Dec 7.
6
Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.在2型糖尿病患者中,三甲胺N-氧化物水平升高预示着高死亡风险,且独立于血糖控制情况。
Clin Chem. 2017 Jan;63(1):297-306. doi: 10.1373/clinchem.2016.263640. Epub 2016 Nov 18.
7
Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.利福昔明可降低肝硬化患者急性肾损伤和肝肾综合征的发生率及严重程度。
Dig Dis Sci. 2016 Dec;61(12):3621-3626. doi: 10.1007/s10620-016-4313-0. Epub 2016 Sep 21.
8
Oxygen metabolism and barrier regulation in the intestinal mucosa.肠道黏膜中的氧代谢与屏障调节
J Clin Invest. 2016 Oct 3;126(10):3680-3688. doi: 10.1172/JCI84429. Epub 2016 Aug 8.
9
Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.肠道微生物群产生的代谢物氧化三甲胺与稳定型冠状动脉疾病的5年死亡风险:肠道微生物群在类似COURAGE研究患者队列中的作用
J Am Heart Assoc. 2016 Jun 10;5(6):e002816. doi: 10.1161/JAHA.115.002816.
10
Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.血浆三甲胺 N-氧化物,一种肠道微生物产生的磷脂酰胆碱代谢产物,与动脉粥样硬化负担相关。
J Am Coll Cardiol. 2016 Jun 7;67(22):2620-8. doi: 10.1016/j.jacc.2016.03.546.